Found 8 results.
Apr, 30 2026 (v1) - Other (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project postcard
Apr, 30 2026 (v1) - Other (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project flyer
Apr, 30 2026 (v1) - Image (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project roll-up
Jan, 01 2026 (v1) - Other (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project 4th Newsletter
Jul, 01 2025 (v1) - Other (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project 3rd Newsletter
Dec, 01 2024 (v1) - Other (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project 2nd newsletter
Jun, 01 2024 (v1) - Other (Open Access)
Uploaded on Apr, 30 2026
ARISTOTELES project 1st newsletter
Jan, 20 2025 (v1) - Publication (Open Access)
Lip, Gregory;
on behalf of the ARISTOTELES consortium
Uploaded on May, 21 2025
Atrial fibrillation (AF) is the most common arrhythmia worldwide, contributing significantly to morbidity, healthcare costs, and resource utilization. Patients with AF face a higher mortality and morbidity from stroke, heart failure, dementia, and hospitalizations. Oral anticoagulants (OACs) are the cornerstone of AF management, as they substantially reduce the risk of stroke and mortality. Nevertheless, some residual risk still remains despite anticoagulation, with most AF-related mortality linked to cardiovascular causes and comorbidities rather than stroke alone.